Compass Therapeutics Inc. (CMPX)

Compass Therapeutics Inc. (CMPX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $150M; returns 1 day -5.1%, 1 week -11.5%, 1 year -80.4%.

Compass Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing proprietary antibody-based therapeutics for oncology. The company's business model is centered on advancing its pipeline through clinical trials to gain regulatory approval. As it has no approved products, it does not generate revenue from product sales.

Groups CMPX belongs to

• Biotechnology
• Clinical Stage Biotech
• Oncology
• Bispecific Antibodies
• Biopharmaceutical
• Antibody Therapeutics
• Healthcare
• Cancer Therapeutics
• Immunotherapy
• Life Sciences

CMPX financial model: income statement, cash flow and balance sheet